eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
6/2024
vol. 16
 
Share:
Send email
Share:
Original paper

Efficacy of adjuvant external beam radiotherapy and brachytherapy in squamous cell carcinoma of oral tongue: Long-term outcomes

Shayan Shojaei
1
,
Asma Mousavi
1
,
Payman Rahimzadeh
1
,
Ali Kazemian
2
,
Mahdi Aghili
3
,
Reza Ghalehtaki
2, 3

  1. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. Department of Radiation Oncology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  3. Radiation Oncology Research Center (RORC), Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran
J Contemp Brachytherapy 2024; 16, 6: 398–409
DOI: https://doi.org/10.5114/jcb.2024.146837
Online publish date: 2024/12/31
Article file
- Efficacy of adjuvant.pdf  [0.56 MB]
Get citation
 
 
1. Siegel RL, Miller KD, Fuchs HE et al. Cancer statistics, 2022. CA Cancer J Clin 2022; 72: 7-33.
2. Liang XH, Lewis J, Foote R et al. Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. J Oral Maxillofac Surg 2008; 66: 1875-1880.
3. Mahuli AV, Sagar V, Kumar A et al. A systematic review and meta-analysis assessing the role of oral health as a risk factor in oral cancer. Cureus 2023; 15: e39786.
4. Johnson DE, Burtness B, Leemans CR et al. Head and neck squamous cell carcinoma. Nat Rev Dis Primers 2020; 6: 92.
5. Nisi KW, Foote RL, Bonner JA et al. Adjuvant radiotherapy for squamous cell carcinoma of the tongue base: improved local-regional disease control compared with surgery alone. Int J Radiat Oncol Biol Phys 1998; 41: 371-377.
6. Chen SW, Zhang Q, Guo ZM et al. Trends in clinical features and survival of oral cavity cancer: fifty years of experience with 3,362 consecutive cases from a single institution. Cancer Manag Res 2018; 10: 4523-4535.
7. Caudell JJ, Gillison ML, Maghami E et al. NCCN Guidelines® insights: Head and neck cancers, version 1.2022: Featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2022; 20: 224-234.
8. Sinha N, Rigby MH, McNeil ML et al. The histologic risk model is a useful and inexpensive tool to assess risk of recurrence and death in stage I or II squamous cell carcinoma of tongue and floor of mouth. Mod Pathol 2018; 31: 772-779.
9. Cabrera-Rodríguez JJ. The role of radiotherapy in the treatment of oral cavity cancer. Plast Aesthet Res 2016; 3: 158-166.
10. Kazemian A, Babaei M, Lashkari M et al. Adjuvant high-dose-rate brachytherapy in the management of oral cavity cancers: 5 years of experience in Iran. J Contemp Brachytherapy 2017; 9: 323-329.
11. Lim YJ, Kong M. Population-based comparative survival analysis of surgery with or without adjuvant radiotherapy and non-operative primary radiotherapy in patients with early-stage oral tongue squamous cell carcinoma. PLoS One 2021; 16: e0259384.
12. Nulent TJK, Noorlag R, Van Cann EM et al. Intraoral ultrasonography to measure tumor thickness of oral cancer: A systematic review and meta-analysis. Oral Oncol 2018; 77: 29-36.
13. Mermod M, Tolstonog G, Simon C et al. Extracapsular spread in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 2016; 62: 60-71.
14. Shin YS, Koh YW, Kim SH et al. Radiotherapy deteriorates postoperative functional outcome after partial glossectomy with free flap reconstruction. J Oral Maxillofac Surg 2012; 70: 216-220.
15. Guinot JL, Bacorro W, Budrukkar A et al. GEC-ESTRO recommendations for head & neck cancer brachytherapy (interventional radiotherapy): 2nd update with focus on HDR and PDR. Radiother Oncol 2024; 201: 110533.
16. Tuček L, Petera J, Sirák I et al. Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancer. Rep Pract Oncol Radiother 2011; 16: 243-247.
17. Tuček L, Vošmik M, Petera J. Is there still a place for brachytherapy in the modern treatment of early-stage oral cancer? Cancers 2022; 14: 222.
18. Harrison L, Zelefsky M, Sessions R et al. Base-of-tongue cancer treated with external beam irradiation plus brachytherapy: oncologic and functional outcome. Radiology 1992; 184: 267-270.
19. Grimard L, Esche B, Lamothe A et al. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies. Head Neck 2006; 28: 888-895.
20. Rodin J, Bar-Ad V, Cognetti D et al. A systematic review of treating recurrent head and neck cancer: a reintroduction of brachytherapy with or without surgery. J Contemp Brachytherapy 2018; 10: 454-462.
21. Bhalavat R, Budrukkar A, Laskar SG et al. Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines. J Contemp Brachytherapy 2020; 12: 501-511.
22. Duncan N. Declaration of Helsinki. World Medical Journal 2013; 59.
23. Kim K, Lee DJ. The updated AJCC/TNM staging system for oral tongue cancer. Transl Cancer Res 2019; 8 (Suppl 2): S164.
24. Lang K, Baur M, & Held T et al. Definitive radiotherapy for squamous cell carcinoma of the oral cavity: a single-institution experience. Radiol Oncol 2021; 55: 467-473.
25. Katz O, Nachalon Y, Hilly O et al. Radiotherapy in early-stage tongue squamous cell carcinoma with minor adverse features. Head Neck 2017; 39: 147-150.
26. Gore SM, Crombie AK, Batstone MD et al. Concurrent chemoradiotherapy compared with surgery and adjuvant radiotherapy for oral cavity squamous cell carcinoma. Head Neck 2015; 37: 518-523.
27. Santos M, Guinot JL, Tortajada M et al. Is perioperative brachytherapy effective in carcinoma of the tongue? J Contemp Brachytherapy 2022; 14: 23-28.
28. Bansal A, Ghoshal S, Oinam AS et al. High-dose-rate interstitial brachytherapy in early stage oral tongue cancer – 15 year experience from a tertiary care institute. J Contemp Brachytherapy 2016; 8: 56-65.
29. Abdalmear MM, Tomita M, Shibuya H. Long-term results of brachytherapy in early mobile tongue cancer with 10-year minimal follow-up. Anticancer Res 2013; 33: 317-324.
30. Potharaju M, Hemanth RE, Muthukumaran M et al. Long-term outcome of high-dose-rate brachytherapy and perioperative brachytherapy in early mobile tongue cancer. J Contemp Brachytherapy 2018; 10: 64-72.
31. Takacsi-Nagy Z, Ferenczi O, Major T et al. Results of sole postoperative interstitial, high-dose-rate brachytherapy of T1-2 tongue tumours. Strahlenther Onkol 2022; 198: 812-819.
32. Marra A, Violati M, Broggio F et al. Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study. Acta Otorhinolaryngol Ital 2019; 39: 84-91.
33. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679-94.
34. Trott KR. Cell repopulation and overall treatment time. Int J Radiat Oncol Biol Phys 1990; 19: 1071-1075.
35. Fowler JF. 21 years of biologically effective dose. Br J Radiol 2010; 83: 554-568.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.